Prevention of the Second Stage of Epithelial Loss Is a Potential Novel Treatment for Bronchiolitis Obliterans

Journal of Thoracic and Cardiovascular Surgery - United States
doi 10.1016/j.jtcvs.2012.07.098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Developing a Novel Inhaled Therapeutic for the Treatment of Bronchiolitis Obliterans Syndrome

2019English

The Role of Epithelial-Mesenchymal Transition in the Post-Lung Transplantation Bronchiolitis Obliterans

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2017English

Azithromycin in Bronchiolitis Obliterans: Is the Evidence Strong Enough?

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2006English

Bronchiolitis Obliterans Organizing Pneumonia (BOOP)

Pneumologie
MedicinePulmonaryRespiratory Medicine
2002English

Fatal Bronchiolitis Obliterans Associated With Chrysotherapy

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1984English

Therapeutic Options for Bronchiolitis Obliterans Syndrome After Lung Transplantation

Eurasian Journal of Pulmonology
2016English

Circulating Fibrocytes Correlate With Bronchiolitis Obliterans Syndrome Development After Lung Transplantation: A Novel Clinical Biomarker

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

Orphan Designation: Recombinant Human Club Cell 10 KDa Protein, Treatment of Bronchiolitis Obliterans Syndrome

Case Medical Research
2019English

Familial Occurrence of Bronchiolitis Obliterans Associated With Pulmonary Aspergillosis

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy